Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload

Clinical trial NCT01039636 · COMPLETED

Trial details

NCT number: NCT01039636
Sponsor: FerroKin BioSciences, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Transfusional Iron Overload Beta-thalassemia

Start date: 2009-11-01
Primary completion: 2010-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.